Synovir: The trial could start by mid-1994, the company said.

Celgene Corp. (CELG), Warren, N.J. Product: Synovir (thalidomide) inhibitor of tumor necrosis factor alpha (TNFa) Indication: Prevent activation of HIV infection Status: Entered into a clinical coll...